Augmentin '125' and Rabeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin '125' (amoxicillin; clavulanate potassium) and Rabeprazole (rabeprazole sodium). Common drug interactions include small intestinal obstruction among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin '125' and Rabeprazole. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.



On Aug, 03, 2026

49 people who take Augmentin '125' and Rabeprazole together, and have interactions are studied.

Augmentin '125' and Rabeprazole drug interactions.

What are the common drug interactions of Augmentin '125' and Rabeprazole, by gender? *:

female:

  1. Small intestinal obstruction (blockage in small intestine)
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  5. Vomiting
  6. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  7. Angioedema (rapid swelling of the dermis)
  8. Coagulopathy (blood's ability to clot is impaired)
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Disease recurrence

male:

  1. Asthenia (weakness)
  2. Cellulitis (infection under the skin)
  3. Impaired healing
  4. Insomnia (sleeplessness)
  5. Neck pain
  6. Pain
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Vomiting
  9. Agitation (state of anxiety or nervous excitement)
  10. Back pain

What are the common drug interactions of Augmentin '125' and Rabeprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Back pain
  2. Blood cholesterol increased
  3. Blood triglycerides increased
  4. Cellulitis (infection under the skin)
  5. Diabetes mellitus non-insulin-dependent
  6. Erectile dysfunction
  7. Headache (pain in head)
  8. Joint sprain (an injury to joint surrounding flexible fibres)
  9. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  10. Oedema peripheral (superficial swelling)

40-49:

  1. Gingivitis (inflammation of gums)
  2. Meningioma (a diverse set of tumours arising from the meninges)

50-59:

  1. Agitation (state of anxiety or nervous excitement)
  2. Alanine aminotransferase increased
  3. Anaemia postoperative
  4. Angiopathy (generic term for a disease of the blood vessels)
  5. Arthralgia (joint pain)
  6. Aspartate aminotransferase increased
  7. Asthenia (weakness)
  8. Asthma
  9. Back pain
  10. Blindness

60+:

  1. Asthenia (weakness)
  2. Leukoencephalopathy (disease of the white matter in the brain)
  3. Blood glucose increased
  4. Blood potassium decreased
  5. Bone disorder
  6. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  7. Cardiac failure congestive
  8. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  9. Cellulitis (infection under the skin)
  10. Cerebral infarction (less blood supply to brain resulting tissue damage)

What are the existing conditions these people have? *

  1. High Blood Pressure: 17 people, 34.69%
  2. Pain: 15 people, 30.61%
  3. Insomnia (sleeplessness): 12 people, 24.49%
  4. Stress And Anxiety: 11 people, 22.45%
  5. Multiple Myeloma (cancer of the plasma cells): 11 people, 22.45%
  6. Metastases To Bone (cancer spreads to bone): 11 people, 22.45%
  7. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough): 11 people, 22.45%
  8. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 11 people, 22.45%
  9. Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 6 people, 12.24%
  10. Diabetes: 4 people, 8.16%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '125' and Rabeprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Augmentin '125' and Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin '125' and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rabeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and rabeprazole sodium (the active ingredients of Augmentin '125' and Rabeprazole, respectively), and Augmentin '125' and Rabeprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: